Patents by Inventor Kyung-Lyum Min

Kyung-Lyum Min has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7501503
    Abstract: The invention relates to oligonucleotide agents that inhibit RNase H activity of a retroid virus reverse transcriptase and are useful for inhibiting retroid virus proliferation and preventing or treating a retroid virus infection.
    Type: Grant
    Filed: December 30, 2003
    Date of Patent: March 10, 2009
    Assignee: McGill University
    Inventors: Masad J. Damha, Rami N. Hannoush, Kyung-Lyum Min, Sandra Carriero
  • Patent number: 7439035
    Abstract: The invention relates to a substrate and method for the assay of ribonuclease H activity. The substrate comprises a DNA/RNA heteroduplex molecule having fluorophore and quencher molecules in close proximity, which emit a background level of fluorescence in the absence of ribonuclease H activity due to quenching of the fluorophore as a result of fluorescence resonance energy transfer. Ribonuclease H cleavage of the heteroduplex results in an increase in fluorescence emission due to the destabilization and separation of the DNA and RNA molecules and their associated fluorophore and quencher molecules. The assay method of the present invention is suitable for use in screening (e.g. high throughput screening) for modulators, e.g. inhibitors, of the ribonuclease H activity associated with, for example, reverse transcriptase and ribonuclease H enzymes.
    Type: Grant
    Filed: January 24, 2007
    Date of Patent: October 21, 2008
    Assignee: McGill University
    Inventors: Michael A. Parniak, Kyung-Lyum Min
  • Patent number: 7186520
    Abstract: The invention relates to a substrate and method for the assay of ribonuclease H activity. The substrate comprises a DNA/RNA heteroduplex molecule having fluorophore and quencher molecules in close proximity, which emit a background level of fluorescence in the absence of ribonuclease H activity due to quenching of the fluorophore as a result of fluorescence resonance energy transfer. Ribonuclease H cleavage of the heteroduplex results in an increase in fluorescence emission due to the destabilization and separation of the DNA and RNA molecules and their associated fluorophore and quencher molecules. The assay method of the present invention is suitable for use in screening (e.g. high throughput screening) for modulators, e.g. inhibitors, of the ribonuclease H activity associated with, for example, reverse transcriptase and ribonuclease H enzymes.
    Type: Grant
    Filed: September 11, 2002
    Date of Patent: March 6, 2007
    Assignee: McGill University
    Inventors: Michael A. Parniak, Kyung-Lyum Min
  • Publication number: 20050233455
    Abstract: Oligonucleotides having an internal acyclic linker residue, and the preparation and uses thereof, are described. Such uses include the preparation of acyclic linker-containing antisense oligonucleotides, and their use for the prevention or depletion of function of a target nucleic acid of interest, such as RNA, in a system. Such a prevention or depletion of function includes, for example, the prevention or inhibition of the expression, reverse transcription and/or replication of the target nucleic acid, as well as the cleavage/degradation of the target nucleic acid. Accordingly, an oligonucleotide of the invention is useful for analytical and therapeutic methods and uses in which the function of a target nucleic acid is implicated, as well as a component of commercial packages corresponding to such methods and uses.
    Type: Application
    Filed: October 29, 2002
    Publication date: October 20, 2005
    Inventors: Masad Damha, Ekaterina Viazovkina, Maria Mangos, Michael Parniak, Kyung-Lyum Min
  • Publication number: 20040138166
    Abstract: The invention relates to oligonucleotide agents that inhibit RNase H activity of a retroid virus reverse transcriptase and are useful for inhibiting retroid virus proliferation and preventing or treating a retroid virus infection.
    Type: Application
    Filed: December 30, 2003
    Publication date: July 15, 2004
    Inventors: Masad J. Damha, Rami N. Hannoush, Kyung-Lyum Min, Sandra Carriero